You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,173,172


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,173,172
Title:Preparation of powder agglomerates
Abstract: The invention relates to a method of producing an agglomerate of drug and solid binder. The process involves producing individual agglomerate particles and then converting the convertible amorphous content of same, following agglomeration, by the application of, for example, moisture. Agglomerates capable of conversion as well as the finished agglomerates and oral and nasal dosing systems including same are also contemplated. The process produces agglomerates which are rugged but which will produce an acceptable fine particle fraction during dosing.
Inventor(s): Yang; Tsong-Toh (Warren, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:11/947,608
Patent Claim Types:
see list of patent claims
Composition; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,173,172: A Comprehensive Analysis

Introduction

Patent analysis is a crucial step in understanding the intellectual property landscape, particularly for businesses and inventors looking to protect or utilize existing innovations. This article delves into the specifics of United States Patent 8,173,172, exploring its scope, claims, and the broader patent landscape.

Patent Overview

United States Patent 8,173,172, hereafter referred to as the '172 patent, is a utility patent granted by the United States Patent and Trademark Office (USPTO). To analyze this patent, one must first understand the basic components of a patent, including the abstract, background, summary, detailed description, and claims.

Abstract and Background

The abstract provides a brief summary of the invention, while the background section contextualizes the problem the invention solves and the state of the art at the time of filing. These sections are essential for understanding the purpose and novelty of the invention.

Summary and Detailed Description

The summary and detailed description sections elaborate on the invention, explaining how it works and its various embodiments. These sections are critical for determining the scope of the patent and how it differs from prior art.

Claims

Independent and Dependent Claims

The claims section is the most critical part of a patent, as it defines the legal scope of the invention. Independent claims stand alone and define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations to the independent claims[3].

Claim Construction

Claim construction is a legal process where the meaning of the claim terms is determined. This process is crucial for patent litigation and is reviewed de novo on appeal. The Federal Circuit has emphasized that claim construction must be done on a claim-by-claim basis, ensuring that each claim is interpreted consistently with the others[2].

Claim Scope and Patent Quality

The scope of patent claims can be measured using metrics such as independent claim length and independent claim count. Narrower claims are often associated with a higher probability of grant and a shorter examination process. The examination process typically narrows the scope of patent claims to ensure clarity and validity[3].

Patent Landscape

Prior Art and Citation Data

Understanding the prior art cited in the patent is essential for assessing its novelty and non-obviousness. Tools like the Common Citation Document (CCD) provide a single point of access to citation data from multiple patent offices, helping to visualize the prior art landscape[1].

Patent Families and Global Dossier

The '172 patent may be part of a larger patent family, which includes related applications filed in different jurisdictions. The Global Dossier service allows users to view the file histories of related applications, including classification, citation data, and office actions, providing a comprehensive view of the patent family[1].

Searching and Analyzing Patents

USPTO Resources

To analyze the '172 patent, one can use various USPTO resources such as the Patent Public Search tool, which offers enhanced access to prior art and modern interfaces for searching. The Public Search Facility and Patent and Trademark Resource Centers (PTRCs) also provide valuable resources for conducting thorough patent searches[1].

Global and National Patent Databases

International databases like PATSTAT and the Global Patent Index can be used to analyze patenting activity globally. These databases help in understanding the geographic distribution of inventions and the priority countries of patent families[4].

Litigation and Validity

Inter Partes Review (IPR)

Patents like the '172 patent can be subject to inter partes review (IPR) proceedings, where the validity of the patent claims is challenged. The Patent Trial and Appeal Board (PTAB) determines the unpatentability of claims, and these decisions can significantly impact the patent's scope and enforceability[2].

Presumption of Validity

United States patents are accompanied by a presumption of validity, which can be challenged through various legal proceedings. The district court's findings on validity, such as those related to written description and anticipation, are critical in determining the patent's enforceability[2].

Economic and Innovation Impact

Patent Scope and Innovation

The scope of patent claims can influence innovation by affecting licensing and litigation costs. Broader claims may lead to increased costs and diminished incentives for innovation, while narrower claims can facilitate clearer boundaries and reduce legal disputes[3].

Geographic Distribution and Inventorship

Patent data can be analyzed to understand the geographic distribution of inventions and the impact of inventorship on patenting activity. This analysis helps in identifying trends and patterns in innovation across different regions and sectors[4].

Key Takeaways

  • Claims Analysis: The claims section of a patent is crucial and must be analyzed on a claim-by-claim basis to understand the legal scope of the invention.
  • Prior Art and Citation Data: Understanding prior art and citation data is essential for assessing the novelty and non-obviousness of the invention.
  • Patent Families and Global Dossier: Analyzing patent families and using tools like the Global Dossier can provide a comprehensive view of related applications and their status.
  • Litigation and Validity: Patents can be subject to IPR proceedings and other legal challenges that impact their validity and enforceability.
  • Economic Impact: The scope of patent claims can influence innovation by affecting licensing and litigation costs.

FAQs

What is the significance of claim construction in patent litigation?

Claim construction is a critical process in patent litigation as it determines the meaning of claim terms, which is reviewed de novo on appeal. It helps in defining the legal scope of the invention and is essential for determining infringement and validity.

How can one measure the scope of patent claims?

The scope of patent claims can be measured using metrics such as independent claim length and independent claim count. These metrics help in understanding the breadth and clarity of the claims.

What is the Global Dossier service, and how does it benefit patent searchers?

The Global Dossier service provides a single portal to access the file histories of related applications from participating IP Offices. It includes features like office action indicators, collections view, and citation data, making it easier to analyze patent families.

How does the USPTO's Patent Public Search tool enhance patent searching?

The Patent Public Search tool offers modern interfaces and enhanced access to prior art, improving the overall patent searching process. It replaced legacy search tools like PubEast and PubWest.

What is the impact of broader versus narrower patent claims on innovation?

Broader claims may lead to increased licensing and litigation costs, diminishing incentives for innovation. Narrower claims, on the other hand, can provide clearer boundaries and reduce legal disputes, facilitating innovation.

Sources

  1. USPTO: "Search for patents - USPTO" - https://www.uspto.gov/patents/search
  2. CAFC: "VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC." - https://cafc.uscourts.gov/opinions-orders/24-1398.OPINION.9-16-2024_2384927.pdf
  3. SSRN: "Patent Claims and Patent Scope" - https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. NCSES: "Invention, Knowledge Transfer, and Innovation" - https://ncses.nsf.gov/pubs/nsb20241/technical-appendix
  5. ACUS: "U.S. Patent Small Claims Court" - https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,173,172

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.